Neal Browning receives a shot in the first-stage study of a potential vaccine for COVID-19, the disease caused by the new coronavirus, Monday, March 16, 2020, at the Kaiser Permanente Washington Health Research Institute in Seattle. Browning is the second patient to receive the shot in the study.
The fall COVID-19 surge has arrived as predicted, and healthcare experts have learned a lot about the virus since the pandemic began. Outbreaks can happen anywhere and COVID-19 can sicken and kill anyone.
The news is encouraging and is positive for U.S. economic growth in the short run. Gus Faucher is the Chief Economist with PNC Financial Services Group and he appears on Smart Talk to share insights for a U.S. recovery.